Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer

被引:0
|
作者
Mónica Fernández-Sánchez
Armando Gamboa-Dominguez
Norma Uribe
Ana Cristina García-Ulloa
Diana Flores-Estrada
Myrna Candelaria
Oscar Arrieta
机构
[1] Instituto Nacional de Ciencias Médicas y Nutrición,Department of Hemato
[2] Instituto Nacional de Ciencias Médicas y Nutrición,Oncology
[3] Universidad Nacional Autónoma de México,Department of Pathology
[4] Instituto Nacional de Cancerologia,Department of Oncology
来源
Medical Oncology | 2006年 / 23卷
关键词
Neoadjuvant chemotherapy; breast cancer; chemotherapy response; cell proliferation; estrogen and progesterone receptors; tumor grade;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:171 / 183
页数:12
相关论文
共 50 条
  • [1] Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer
    Fernández-Sánchez, M
    Gamboa-Dominguez, A
    Uribe, N
    García-Ulloa, AC
    Flores-Estrada, D
    Candelaria, M
    Arrieta, O
    [J]. MEDICAL ONCOLOGY, 2006, 23 (02) : 171 - 183
  • [2] IMMUNOHISTOCHEMICAL PREDICTORS OF THE CLINICAL AND PATHOLOGICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED BREAST CANCER
    Rodionova, M.
    Ryabchikov, D.
    Portnoy, S.
    Vorotnikov, I.
    Chkhikvadze, N.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 130 - 131
  • [3] Pathological and clinical predictors for response to neoadjuvant chemotherapy in breast cancer
    MacGrogan, G
    Pallud, C
    Simonie-Lafontaine, J
    Sagan, C
    Verrielle, V
    Antoine, M
    Ettore, F
    Treilleux, I
    Tas, P
    Bellocq, JP
    Ulusakarya, A
    [J]. LABORATORY INVESTIGATION, 2003, 83 (01) : 39A - 39A
  • [4] Pathological and clinical predictors for response to neoadjuvant chemotherapy in breast cancer
    MacGrogan, G
    Pallud, C
    Simonie-Lafontaine, J
    Sagan, C
    Verrielle, V
    Antoine, M
    Ettore, F
    Treilleux, J
    Tas, P
    Bellocq, JP
    Ulusakarya, A
    [J]. MODERN PATHOLOGY, 2003, 16 (01) : 39A - 39A
  • [5] Clinical, radiological and pathological assessment of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Srivastava, A
    Bosu, NK
    Coshic, O
    Kumar, A
    Dawar, R
    Bandhu, S
    Goyal, A
    [J]. BRITISH JOURNAL OF CANCER, 2001, 85 : 49 - 49
  • [6] The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients
    Stamatovic, Ljiljana
    Susnjar, Snezana
    Gavrilovic, Dusica
    Minic, Ivana
    Ursulovic, Tamara
    Dzodic, Radan
    [J]. JOURNAL OF BUON, 2018, 23 (05): : 1273 - 1280
  • [7] The influence of breast cancer subtypes on response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients
    Susnjar, S.
    Stamatovic, L.
    Gavrilovic, D.
    Minic, I.
    Ursulovic, T.
    [J]. BREAST, 2017, 32 : S81 - S82
  • [8] Clinical and pathological response to neoadjuvant chemotherapy with different chemotherapy regimens predicts the outcome of locally advanced breast cancer
    Tang, Shicong
    Wang, Ke
    Zheng, Kai
    Liu, Jiadong
    Zhang, Hengyu
    Tan, Mingjian
    Li, Hongwan
    Li, Huimeng
    Tan, Xin
    Liu, Dequan
    Guo, Rong
    [J]. GLAND SURGERY, 2020, 9 (05) : 1415 - +
  • [9] Predictors of response to neoadjuvant chemotherapy in women with locally advanced breast cancer.
    Parmar, V
    Nadkarni, M. S.
    Hawaldar, R.
    Shet, T.
    Nair, R.
    Gupta, S.
    Chinoy, R.
    Badwe, R.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S172 - S173
  • [10] Topoisomerase 2 alpha as a predictor of response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer
    Shehata, M.
    Al-Attar, A.
    Reis-Filho, J.
    Ellis, I.
    Mukherjee, A.
    Chan, S.
    [J]. BREAST CANCER RESEARCH, 2010, 12 : S14 - S15